Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > Wer legt den Shorties das Handwerk!
View:
Post by Charly50 on Jan 31, 2021 1:47am

Wer legt den Shorties das Handwerk!

Big Pharma: Das Ende der Zurckhaltung! Stammzelltherapien: Diabetes, Herzschwche, Parkinson - Stammzellen sollen alles heilen. Pfizer bernimmt die Fhrung in dem potentiell hchst lukrativem Geschft mit Stammzelltherapien. Der Schweizer Pharmakonzern Roche zahlte Millionen US-Dollar um Zugriff auf deren innovative Stammzell-Technologien zu erhalten. Rangelei um die Pltze ! Die Liste der Firmen liee sich noch beliebig erweitern: Fr Novartis, GlaxoSmithKline und AstraZeneca (Nummer 2, 5 und 7 auf der Liste der grten Pharmaunternehmen) sind hnliche Aktivitten zu verzeichnen. Wie bei Roche geht es anfnglich um den Test von pharmakologischen Substanzen im Labor, doch muss man kein Prophet sein, um dies auch als Einstieg in das Therapiegeschft zu deuten. Die Rangelei um die Pltze am Fleischtopf hat begonnen. Quelle: wissensschau.de
Comment by AlfonzoBall on Jan 31, 2021 10:06am
Big Pharma: The end of restraint! Stem cell therapies: Diabetes, heart disease, Parkinson's disease - stem cells are supposed to cure everything. Pfizer takes the lead in the potentially most lucrative business with stem cell therapies. The Swiss pharmaceutical company Roche paid millions of US dollars to gain access to their innovative stem cell technologies. Scramble for the top spots ! The ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities